Candibiotic drops, 5 ml

Allergic and inflammatory ear diseases, including:

• acute diffuse otitis externa;

• acute otitis media;

• chronic otitis media in the acute stage;

• condition after ear surgery.

Locally, 4-5 drops into the external auditory canal, 3-4 times a day. Improvement occurs within 3-5 days. The course of treatment is 7-10 days.

Ear drops

1 ml

active substances:

chloramphenicol 50 mg

beclomethasone dipropionate (anhydrous) 0.25 mg

clotrimazole 10 mg

lidocaine hydrochloride monohydrate (in terms of lidocaine hydrochloride) 20 mg

excipients: glycerol; propylene glycol

-Hypersensitivity to the components of the drug;

- violation of the integrity of the tympanic membrane;

-Children under 6 years old.

pharmachologic effect

The drug has a local antimicrobial, antibacterial, anti-inflammatory and local anesthetic effect.

Chloramphenicol is a broad-spectrum bacteriostatic antibiotic. Disrupts the process of protein synthesis in the microbial cell. Active against gram-positive and gram-negative bacteria.

Beclomethasone dipropionate - GCS. It has anti-inflammatory and anti-allergic effects.

Clotrimazole (an imidazole derivative) is a broad-spectrum antifungal agent for topical use. The antifungal effect of clotrimazole is associated with a violation of the synthesis of ergosterol, which is part of the cell membrane of fungi, which changes the membrane permeability and causes subsequent cell lysis.

Lidocaine is a local anesthetic. It causes a reversible blockade of impulse conduction along nerve fibers by blocking the passage of sodium ions through the membrane.

Side effect

Local reactions: rarely - itching, burning at the site of application of the drug; allergic reactions are possible.

From the side of the organ of vision: rarely - blurry vision.

Application during pregnancy and lactation

The question of the advisability of prescribing the drug during pregnancy is decided by the doctor individually. Prescribing a drug is possible when the expected benefit of therapy to the mother outweighs the potential risk to the fetus.

Application in children

The use of the drug is contraindicated in children under 6 years of age.

special instructions

Visual impairment

With systemic and local use of GCS, visual impairment may occur. If the patient has symptoms such as blurred vision or other visual impairments, the patient should be advised to see an ophthalmologist to identify possible causes of visual impairment, including cataracts, glaucoma, or rare diseases, such as central serous chorioretinopathy (CSH), which have been observed with systemic and local application of GCS.